Clinical-Backed Innovation
Our flagship “UTH” series of NAD⁺ boosters is founded on clinically driven innovation focused on advancing healthy aging. Since 2017, we have been committed to translating cutting-edge biotechnology into evidence-based health solutions. Uthever® NMN, our flagship ingredient, has completed large-scale human clinical trials, establishing a strong benchmark for safety and efficacy within the industry. In addition, our premium NAD+ booster product line, UthPeak® NMNH (reduced NMN) has also completed rigorous human clinical validation, further expanding the depth and scope of our longevity research.
Building on this scientific foundation, our LipoAvail® liposomal technology has achieved successful human clinical validation with liposomal Vitamin C and liposomal NAD⁺, with additional high-potential ingredients planned for future study. Through continued clinical substantiation and technological innovation, we remain dedicated to delivering clinically-backed solutions that support healthier aging worldwide.
We understand that clinical validation is the crucial link between scientific innovation and practical application, forming the foundation of our commitment to users worldwide. In our pursuit of excellence, we consistently prioritize clinical validation to ensure the safety, effectiveness, and evidence-based results of each product, providing reliable health assurances to our global audience.
Driven by a deep passion for technology and a profound respect for life and health, we continually challenge ourselves and embrace our responsibilities. Looking ahead, EffePharm will continue collaborating with global partners, using clinical validation as a solid foundation to explore the limitless possibilities in the health sector. Together, we aim to open new chapters for a healthier future and significantly contribute to humanity’s health and well-being.
Together, We Build a Brighter Future
Tech-Driven Innovation
Unlock the Power of Biotechnology Through Innovation
- Chemical Synthesis
- Enzyme Catalysis
- Cell Factory / Biosynthesis
Synthetic Biology:
Powerhouse Behind InnovationEffeBio, our synthetic biology research center, is a cornerstone of our technological initiatives, driving innovation and strengthening our core competitiveness and sustainable growth. Through genetic modification of traditional fermentation strains, we have achieved breakthroughs in the industrialization and intelligent manufacturing of cell factories. This progress lays a robust foundation for product and process technology upgrades, lowering costs while promoting safety, environmental protection, and energy conservation—ultimately energizing EffePharm’s continued development.
From Research to Reality:
Technology Chain Powering Anti-AgingEffePharm has adopted a streamlined business model focused on “research and development – small/medium-scale trials – industrialization.” Using our microbial technology platform, we design customized cell factories to synthesize targeted compounds. Applying synthetic biology principles, our team utilizes advanced methods such as deep chassis modification, directed enzyme evolution, high-throughput screening, and multi-scale fermentation process control. This approach has successfully created several anti-aging product lines, including ergothioneine, PQQ, resveratrol, spermidine, and NMN. The industrialization of microbial cell factories for NMN and ergothioneine is a major milestone, marking EffePharm’s progress in the anti-aging industry.
A Greener Path Forward:
Intelligent Manufacturing for SustainabilityEffeBio’s establishment marks a key milestone for EffePharm, ensuring full technology chain coverage in the anti-aging sector. This center focuses on engineering microorganisms to develop novel anti-aging molecules, optimizing their synthesis and accumulation for more effective solutions. We’ve built specialized modules, including molecular component assembly, chassis cell optimization, and fermentation engineering. Leveraging our industrial strengths, we’ve implemented fermentation-based production of NMN and ergothioneine. Moving forward, EffePharm plans to boost R&D investments, advance synthetic biology, and achieve sustainable, green intelligent manufacturing.
Your Success, Our Mission
At EffePharm, your success is at the heart of our mission. We are committed to equipping you with data-driven insights and innovative nutritional solutions that propel your growth in the nutrition industry. By leveraging cutting-edge technology, we offer a diverse range of nutrient applications customized to meet your specific needs and surpass market expectations. Together, we can forge a path to a healthier future, ensuring that your goals align perfectly with our dedication to excellence. Choose EffePharm—where your success inspires our passion.